首页 | 本学科首页   官方微博 | 高级检索  
     

甲基丙二酸血症14例诊断及治疗分析
引用本文:Jin H,Zou LP,Zhang CH,Fang F,Xiao J,Wu HS,Zhu C,Guo W,Jin Z. 甲基丙二酸血症14例诊断及治疗分析[J]. 中华儿科杂志, 2004, 42(8): 581-584
作者姓名:Jin H  Zou LP  Zhang CH  Fang F  Xiao J  Wu HS  Zhu C  Guo W  Jin Z
作者单位:1. 100045,北京,首都医科大学附属北京儿童医院神经内科
2. 日本金泽医科大学生命科学研究所
3. 100045,北京,首都医科大学附属北京儿童医院内科
4. 北京中日友好临床医学研究所
5. 解放军三○六医院磁共振室
摘    要:目的 探讨甲基丙二酸血症(MMA)的临床特征和治疗方法。方法 对14例MMA患儿的临床资料进行总结分析。结果 14例中男4例,女10例,发病年龄自出生~9岁,生后1个月内发病者7例(50%),1岁以内发病者共10例(71%)。主要临床表现有嗜睡(6例)、智力体力发育落后或倒退(7例)、惊厥(6例)、发作性呕吐(4例)、喂养困难(4例)、肌张力异常(低下5例,增高3例)、毛发黄(4例)等。血气分析提示代谢性酸中毒6例,高氨血症5例,酮尿4例,气相色谱-质谱法(GC/MS)尿有机酸分析显示14例患儿尿甲基丙二酸浓度均明显高于正常,头颅CT检查6例中5例异常,MRI检查5例全部异常,4例肌电图中2例提示有周围神经病变。3例在确诊前死亡,11例确诊患儿中10例接受维生素B12(VitB12)治疗,辅以低蛋白饮食及左旋肉碱治疗。对治疗的7例进行3个月~1年6个月(平均8.5个月)的随访,1例临床症状完全消失,4例明显好转,2例死于严重代谢性酸中毒。结论 嗜睡、智力体力发育落后或倒退、惊厥、发作性呕吐、喂养困难、肌张力异常、毛发黄、代谢性酸中毒、高氨血症、酮尿是MMA的主要临床特征,GC/MS法尿有机酸分析是早期诊断MMA的重要依据,确诊后坚持长期合理治疗是改善预后的有效方法。

关 键 词:甲基丙二酸血症 诊断 治疗 临床特征 小儿 先天性有机酸代谢异常

Diagnosis and treatment of methylmalonic acidemia in 14 cases
Jin Hong,Zou Li-Ping,Zhang Chun-Hua,Fang Fang,Xiao Jing,Wu Hu-Sheng,Zhu Cheng,Guo Wei,Jin Zhen. Diagnosis and treatment of methylmalonic acidemia in 14 cases[J]. Chinese journal of pediatrics, 2004, 42(8): 581-584
Authors:Jin Hong  Zou Li-Ping  Zhang Chun-Hua  Fang Fang  Xiao Jing  Wu Hu-Sheng  Zhu Cheng  Guo Wei  Jin Zhen
Affiliation:Department of Neurology, Beijing Children's Hospital, Capital University of Medical Sciences, Beijing, 100045 China.
Abstract:Objective Methylmalonic acidemia (MMA) is one of the most common disorders of congenital organic acid metabolism. This study aimed at exploring the clinical characteristics and treatment of the disease to help improve our understanding of it. Methods The clinical data of 14 patients with MMA admitted to our hospital between January 2002 and July 2003 were analyzed and the diagnoses were confirmed by gas chromatography/mass spectrometry (GC/MS). The patients consisted of 4 males and 10 females, whose age of onset ranged from birth to 9 years with 7 cases younger than 1 month (50% ) and 10 cases younger than 1 year (71%). Results The main clinical manifestations were lethargy (6 cases), developmental retardation or regradation (7 cases) , convulsion (6 cases) , recurrent vomiting (4 cases) , difficulty with feeding (4 cases) , muscular dystonia (5 cases with hypotonia, 3 with hypertonia) and yellowish hair (4 cases) , etc. Some cases were also presented with hair loss, hepatomegaly, ataxic or stiff gait, and motor weakness with muscular atrophy. The laboratory findings showed metabolic acidosis in 6 cases, hyperammonemia in 5 cases, ketonuria in 4 cases and remarkable elevation of urinary methylmalonic acid concentration in all cases. Some abnormalities in globus pallidus and cerebral white matter as well as diffuse cerebral atrophy were noted by the brain CT and MRI in 5 respective cases, while 4 cases did not receive neuroradiological examinations. Peripheral neuropathies were found by electromyography in 2 patients and bilateral optic nerve atrophy was detected by eyeground examination in 1 child. Three patients died before the diagnoses were made. Of the 11 survivals, 10 children have received therapy of vitamin B12 (VitB12) and supplementation of L-carnitine with restricted-protein diet The follow-up for a period ranging from 3 months to 1. 5year ( mean 8. 5 months) of 7 cases with medical therapy showed a favorable outcome without any symptoms in 1 case and apparent improvement in 4 cases (the diffuse cerebral atrophy in MRI completely recovered in one case) , however, 2 patients died from severe metabolic acidosis. Conclusions The main clinical features of MMA include lethargy, developmental retardation or regradation, convulsion, recurrent vomiting, difficulty with feeding, muscular dystonia, yellowish hair, metabolic acidosis, hyperammonemia and ketonuria, etc. Urine organic acids analysis with GC/MS is critical to the early diagnosis of MMA. Early diagnosis and appropriate long-term treatment are essential to improve the prognosis of the disease.
Keywords:Methylmalonic acid  Vitamin B12  Mass fragmentography
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号